Cyndee Miranda

Cyndee Miranda

Auto-generated profile, based on publicly available information

Cyndee Miranda

Department of Infectious Disease, Cleveland Clinic Foundation, Cleveland, Ohio

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2025 in Clinical Infectious Diseases
Verified
Journal Article
Closed access
ZYZachary A Yetmar
Zachary A Yetmar
PMPaige K Marty
Paige K Marty
JCJosh Clement
Josh Clement
CMCyndee Miranda
Cyndee Miranda
Nancy WengenackNancy Wengenack
Nancy Wengenack
EBElena Beam
Elena Beam
Nocardiosis is an uncommon yet potentially devastating infection. Nocardia tends to affect individuals with chronic lung disease or immunocompromising conditions, 2 groups increasing in number. Incidence of nocardiosis is likely to increase as well, and it is vital to have an approach to this complex disease. Here, we aim to review the presentation, diagnosis, and management of Nocardia in the modern era. We will also highlight areas of uncertainty in our understanding of nocardiosis and propose a general approach to nocardiosis therapy, accounting for response and tolerance of Nocardia treatment.

1 March 2009 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Closed access
PDF file
CMCyndee Miranda
Cyndee Miranda
BYBelinda Yen-Lieberman
Belinda Yen-Lieberman
PTPaul Terpeluk
Paul Terpeluk
JTJ. Walton Tomford
J. Walton Tomford
SGSteven Gordon
Steven Gordon
Reducing the Rates of Indeterminate Results of the QuantiFERON-TB Gold In-Tube Test During Routine Preemployment Screening for Latent Tuberculosis Infection Among Healthcare Personnel - Volume 30 Issue 3 - Cyndee Miranda, Belinda Yen-Lieberman, Paul Terpeluk, J. Walton Tomford, Steven Gordon

26 December 2025 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
MBMaria Vega Brizneda
Maria Vega Brizneda
CMCyndee Miranda
Cyndee Miranda
ECEric Cober
Eric Cober
AMAnisha Misra
Anisha Misra
SHSusan Harrington
Susan Harrington
ZYZachary A Yetmar
Zachary A Yetmar
Background: Nocardiosis primarily affects immunocompromised hosts and those with chronic pulmonary disease but can also occur in immunocompetent patients. Predictors of dissemination and its role in long-term mortality remain unclear. Methods: We conducted a retrospective cohort study of adults with nocardiosis diagnosed from January 1, 2010 to December 31, 2023. Patients were categorized into 3 groups: immunocompromised, immunocompetent with chronic lung disease, and immunocompetent without chronic lung disease. We evaluated risk factors associated with dissemination at the time of diagnosis and predictors of 1-year mortality. Multivariable logistic regression identified risk factors for dissemination. Cox regression assessed predictors of 1-year mortality. Results: Among 232 patients, 44 (19.0%) had disseminated infection and 36 (15.5%) died within 1-year. Dissemination was more common among patients who were immunocompromised (odds ratio ([OR] 6.26, 95% confidence interval [CI] 2.26–20.53) or immunocompetent without chronic lung disease (OR 5.09, 95% CI 1.75–17.15). Lymphopenia and infection with Nocardia farcinica were also independently associated with dissemination. Dissemination was not associated with mortality overall (hazard ratio [HR] 1.58, P = .222), though interaction analysis revealed that dissemination was significantly associated with 1-year mortality only in immunocompetent patients with chronic lung disease (HR 9.43, 95% CI 1.73–51.52). Conclusions: Immunocompromised patients and those without chronic lung disease are at increased risk for disseminated nocardiosis. While dissemination alone is not predictive of 1-year mortality overall, it is directly associated with mortality among immunocompetent patients with chronic lung disease. These findings highlight the need for tailored prognostic assessment and management in this subgroup.

1 September 2010 in Cleveland Clinic Journal of Medicine
Verified
Journal Article
Open access
CMCyndee Miranda
Cyndee Miranda
JTJ. Walton Tomford
J. Walton Tomford
SGSteven M. Gordon
Steven M. Gordon
Although the tuberculin skin test has long been the standard for detecting latent tuberculosis infection, it has many limitations. Interferon-gamma-release assays are gaining acceptance as an alternative. In this paper we present cases to illustrate how these new tests can be used and how to interpret the results.

15 April 2025 in Clinical Infectious Diseases
Verified
Journal Article
Closed access
ZYZachary A Yetmar
Zachary A Yetmar
PMPaige K Marty
Paige K Marty
JCJosh Clement
Josh Clement
CMCyndee Miranda
Cyndee Miranda
Nancy WengenackNancy Wengenack
Nancy Wengenack
EBElena Beam
Elena Beam

1 January 2020 in American Journal of Infection Control
Verified
Journal Article
Closed access
AMAnita R. Modi
Anita R. Modi
CMCyndee C. Miranda
Cyndee C. Miranda
GPGary W. Procop
Gary W. Procop
CFCharles B. Foster
Charles B. Foster
SHSusan Harrington
Susan Harrington
SGSteven M. Gordon
Steven M. Gordon